RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Coexpression of matrix metalloproteinase-7 (MMP7) and phosphorylated insulin growth factor receptor I (pIGF-IR) as predictors of resistance to anti-EGFR therapy in advanced colorectal cancer (ACRC)
A GEMCAD study
Horndler, C., Gallego, R., Alonso, V., Alonso, V., Escudero, P., Jimeno, M., Garcia-Albeniz, X., Fernandez-Martos, C., Castellvi-Bel, S., & Maurel, J. (2009). Coexpression of matrix metalloproteinase-7 (MMP7) and phosphorylated insulin growth factor receptor I (pIGF-IR) as predictors of resistance to anti-EGFR therapy in advanced colorectal cancer (ACRC): A GEMCAD study. Journal of Clinical Oncology, 27(15_suppl ), 4063. https://doi.org/10.1200/jco.2009.27.15_suppl.4063